Remus Pharmaceuticals Ltd (REMP)

2,080.00 +5.05 (+0.24%)
Close INR Disclaimer

REMP Cash Flow Statement

Net Income/Starting Line
Cash From Investing Activities
Mar 31, 2023
Depreciation/Depletion 1.40
Amortization -
Deferred Taxes -
Non-Cash Items -
Cash Receipts -
Cash Payments -
Cash Taxes Paid -
Cash Interest Paid -
Changes in Working Capital -20.42
Capital Expenditures -7.09
Other Investing Cash Flow Items, Total 0.25
Financing Cash Flow Items -0.97
Total Cash Dividends Paid -
Issuance (Retirement) of Stock, Net -
Issuance (Retirement) of Debt, Net -15.32

* In Millions of INR (except for per share items)

Clear All
Please try another search

Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.

Related Articles